L-Citrulline for Acute Lung Injury

AAAQ 9369

L-Citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects

The purpose of this study is to determine whether L-citrulline is effective and safe in the prevention of clinical sequelae of Acute Lung Injury in pediatric subjects undergoing surgery for congenital heart defects.

Are you Eligible? (Inclusion Criteria)

  • UP to 18 years of age
  • Male or female
  • Infants, children and adolescents undergoing cardiac bypass  for repair of a large unrestrictive VSD, an ostium primum ASD, or a partial or complete AVSD

Specialty Area(s)

Trial Location

Morgan Stanley Children's Hospital
3959 Broadway
Babies North, 2nd Floor
New York, NY 10032
United States